(197 days)
3M No Sting Barrier Film, Bard Protective Barrier Film
Not Found
No
The summary describes a topical skin protectant that forms a physical barrier. There is no mention of AI, ML, image processing, or any computational analysis of data.
No
Explanation: While SuperSkin® protects the skin and helps prevent irritation, it does not treat or cure a disease or condition, which is the primary characteristic of a therapeutic device. It acts as a barrier, preventing a problem rather than solving an existing one.
No
The device is described as a skin protectant that forms a flexible coating to protect against irritation and friction. Its purpose is to prevent harm, not to diagnose a condition.
No
The device description clearly states it is a "topically-applied skin protectant" which is a physical substance, not software.
Based on the provided information, this device is NOT an IVD (In Vitro Diagnostic).
Here's why:
- IVDs are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- SuperSkin® is a topically-applied skin protectant. Its function is to create a physical barrier on the skin surface.
- The intended use and device description clearly state its purpose is to protect skin from irritation and friction. It does not involve analyzing any bodily fluids or tissues for diagnostic purposes.
The information provided aligns with a topical medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
SuperSkin® helps to protect skin exposed to irritation from moisture such as sweat, urine, and digestive juices. SuperSkin® can also be used on unbroken skin surfaces that are exposed to friction and shear. Do not apply over broken skin.
Product codes (comma separated list FDA assigned to the subject device)
NEC
Device Description
SuperSkin® is a topically-applied skin protectant for use on unbroken skin. The patient applies between 2-4 drops of SuperSkin® to the intact skin. The liquid polymerizes to form a thin, flexible coating.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Skin
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biological testing of medical materials was performed satisfactorily in accordance with the guidelines found in ISO 10993; bioburden assays were performed; and, the product was evaluated for safety in a chronic irritation setting and for performance characteristics for friction reduction and moisture protection in a clinical model.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
3M No Sting Barrier Film, Bard Protective Barrier Film
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5090 Liquid bandage.
(a)
Identification. A liquid bandage is a sterile device that is a liquid, semiliquid, or powder and liquid combination used to cover an opening in the skin or as a dressing for burns. The device is also used as a topical skin protectant.(b)
Classification. Class I (general controls). When used only as a skin protectant, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 880.9.
0
大972081
DEC I 7 1997
510(k) Summarv
Michael Byram, CEO, MedLogic Global Corporation, Ste 111, 4815 Applicant: List Drive, Colorado Springs, CO 80919
1-719-540-8200 (telephone) 1-719-535-8999 (facsimile)
June 3, 1997 Date:
SuperSkin® Name:
Classification: Skin Protectant; 21 CFR § 880.5090.
3M No Sting Barrier Film; Bard Protective Barrier Film Predicate:
SuperSkin® is a topically-applied skin protectant for use on unbroken Description: skin. The patient applies between 2-4 drops of SuperSkin® to the intact skin. The liquid polymerizes to form a thin, flexible coating.
Intended Use: SuperSkin® helps to protect skin exposed to irritation from moisture such as sweat, urine, and digestive juices.
SuperSkin® can also be used on unbroken skin surfaces that are exposed to friction and shear.
Do not apply over broken skin.
Technological
Characteristic: SuperSkin® demonstrates appropriate biocompatability and non-toxicity for its intended use; the product is intended for application to skin in a nonsterile aseptic format; and, the product provides equivalent performance in terms of moisture barrier, vapor penetration, shear protection, friction reduction, and chronic irritation to the predicate product.
Data
Biological testing of medical materials was performed satisfactorily in Submitted: accordance with the guidelines found in ISO 10993; bioburden assays were performed; and, the product was evaluated for safety in a chronic irritation setting and for performance characteristics for friction reduction and moisture protection in a clinical model.
1
Image /page/1/Picture/2 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized image of three human profiles facing right, stacked on top of each other. The profiles are connected by a flowing line that resembles a river or stream. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" is arranged in a circular pattern around the image.
OCT 1 6 2006
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Medlogic Global Corporation % Mr. Jur Strobos Greenberg & Traurig 1300 Connecticut Avenue, N.W. Suite 1000 Washington, D. C. 20036
Re: K972081 Trade/Device Name: SuperSkin® Regulation Number: 21 CFR 880.5090 Regulation Name: Bandage, liquid, skin protectant liquid bandage Regulatory Class: I (exempt) Product Code: NEC Dated: September 29, 1997 Received: September 29, 1997
Dear Mr. Strobos:
This letter corrects our substantially equivalent letter of December 17, 1997.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
2
Page 2 - Mr. Jur Strobos
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
erely yours,
arbare Buchner
for
Mark N. Melke Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
| 510(k) Number (if known): | |
|---|---|
| Device Name: | SuperSkin |
| Indications For Use: |
SuperSkir® helps to protect skin exposed to irritation from moisture such as sweat, urine,
and digestive juices.
SuperSkin® can also be used on unbroken skin surfaces that are exposed to friction and the
shear. shear.
Do not apply over broken skin
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
-t
Division of General Restorative Device
510(k) Number
Prescription Use (Per 21 CFR 801.109)
ଠନ୍ନ
: !
Over-The-Counter Use
(Optional Formal 1-2-96)